🚀 VC round data is live in beta, check it out!
- Public Comps
- China Feihe
China Feihe Valuation Multiples
Discover revenue and EBITDA valuation multiples for China Feihe and similar public comparables like NH Foods, Cranswick, Orion (Spin Co), Uni-President China and more.
China Feihe Overview
About China Feihe
China Feihe is China's largest infant milk formula producer, with a premium market positioning among domestic and foreign competing brands. The company utilizes the flagship Astrobaby lineup to promote its “more suitable for Chinese babies” proposition. It has a nationwide distributor network covering maternity stores, supermarkets and traditional retailers, as well as a direct sales network in e-commerce.
Founded
2012
HQ

Employees
9.6K
Website
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialChina Feihe Financials
China Feihe reported last 12-month revenue of $3B and EBITDA of $589M.
In the same LTM period, China Feihe generated $2B in gross profit, $589M in EBITDA, and $305M in net income.
Revenue (LTM)
China Feihe P&L
In the most recent fiscal year, China Feihe reported revenue of $3B and EBITDA of $576M.
China Feihe is profitable as of last fiscal year, with gross margin of 65%, EBITDA margin of 22%, and net margin of 11%.
Financial data powered by Morningstar, Inc.
China Feihe Stock Performance
China Feihe has current market cap of $4B, and enterprise value of $2B.
Market Cap Evolution
China Feihe's stock price is $0.44.
China Feihe share price decreased by 42.8% in the last year.
China Feihe has an EPS (earnings per share) of $0.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $4B | -0.0% | 0.0% | -8.5% | -42.8% | $0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialChina Feihe Valuation Multiples
China Feihe trades at 0.6x EV/Revenue multiple, and 2.8x EV/EBITDA.
EV / Revenue (LTM)
China Feihe Financial Valuation Multiples
As of May 3, 2026, China Feihe has market cap of $4B and EV of $2B.
China Feihe has a P/E ratio of 12.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified China Feihe Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


China Feihe Margins & Growth Rates
China Feihe grew revenue by 3% and EBITDA by 6% in the last fiscal year.
In the most recent fiscal year, China Feihe reported gross margin of 65%, EBITDA margin of 22%, and net margin of 11%.
China Feihe Margins
China Feihe Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
China Feihe Operational KPIs
China Feihe's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
China Feihe's Rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
China Feihe's Rule of X is 30% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
China Feihe Competitors
China Feihe competitors include NH Foods, Cranswick, Orion (Spin Co), Uni-President China, Vita Coco, a2 Milk, Coca-Cola Andina, United Breweries, Yamazaki Baking and Kewpie.
Most China Feihe public comparables operate across Food & Beverages and Baby & Child Care.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.5x | 0.5x | 9.1x | 7.5x | |||
| 1.1x | 1.0x | 10.6x | 9.1x | |||
| 1.3x | 1.3x | 6.1x | 5.9x | |||
| 0.7x | 0.7x | 5.8x | 6.3x | |||
| 5.9x | 5.6x | 36.9x | 32.3x | |||
| 2.9x | 2.8x | 17.5x | 19.6x | |||
| 1.3x | 1.3x | 6.9x | 6.9x | |||
| 3.9x | 4.1x | 41.6x | 41.7x | |||
This data is available for Pro users. Sign up to see all China Feihe competitors and their valuation data. Start Free Trial | ||||||
China Feihe M&A Activity
China Feihe has acquired 1 company to date.
Last acquisition by China Feihe was on December 19th 2017. China Feihe acquired Vitamin World for $28M (EV/Revenue multiple of ).
Latest Acquisitions by China Feihe
| Description | Vitamin World is a nationwide retailer of vitamins and nutritional supplements with over 380 stores across the United States. It sources premium ingredients globally to formulate high-potency products for wellness needs ranging from immunity to fitness. Trained associates in each location provide personalized guidance to customers from beginners to enthusiasts. Headquartered in Hauppauge, New York, the brand emphasizes purity and freshness in its offerings since its founding in 1976. |
| HQ Country | |
| HQ City | New York City, NY |
| Deal Date | 19 Dec 2017 |
| Valuation | $28M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all China Feihe acquisitions and their M&A valuation multiples. Start Free Trial | |
China Feihe Investment Activity
China Feihe has invested in 1 company to date.
Latest investment by China Feihe was on March 1st 2021. China Feihe invested in Gushengtang Holdings in their $38M Series E round (EV/Revenue multiple of ).
Latest Investments by China Feihe
| Description | Gushengtang Holdings Ltd is a traditional chinese medicine (TCM) company. Through offline medical institutions and online healthcare platforms, it provides customers with a comprehensive range of TCM healthcare services and products to address diverse medical and healthcare management needs. All of the group’s revenue is derived from the PRC. |
| HQ Country | |
| HQ City | Guangzhou |
| Deal Date | 1 Mar 2021 |
| Round | Series E |
| Raised | $38M |
| Investors | Eight Roads Ventures; China Feihe; Long Hill Capital; New Enterprise Associates |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all China Feihe investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout China Feihe
| When was China Feihe founded? | China Feihe was founded in 2012. |
| Where is China Feihe headquartered? | China Feihe is headquartered in China. |
| How many employees does China Feihe have? | As of today, China Feihe has over 9K employees. |
| Who is the CEO of China Feihe? | China Feihe's CEO is Youbin Leng. |
| Is China Feihe publicly listed? | Yes, China Feihe is a public company listed on HKEX. |
| What is the stock symbol of China Feihe? | China Feihe trades under 06186 ticker. |
| When did China Feihe go public? | China Feihe went public in 2019. |
| Who are competitors of China Feihe? | China Feihe main competitors include NH Foods, Cranswick, Orion (Spin Co), Uni-President China, Vita Coco, a2 Milk, Coca-Cola Andina, United Breweries, Yamazaki Baking, Kewpie. |
| What is the current market cap of China Feihe? | China Feihe's current market cap is $4B. |
| What is the current revenue of China Feihe? | China Feihe's last 12 months revenue is $3B. |
| What is the current revenue growth of China Feihe? | China Feihe revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of China Feihe? | Current revenue multiple of China Feihe is 0.6x. |
| Is China Feihe profitable? | Yes, China Feihe is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of China Feihe? | China Feihe's last 12 months EBITDA is $589M. |
| What is China Feihe's EBITDA margin? | China Feihe's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of China Feihe? | Current EBITDA multiple of China Feihe is 2.8x. |
| What is the current FCF of China Feihe? | China Feihe's last 12 months FCF is $262M. |
| What is China Feihe's FCF margin? | China Feihe's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of China Feihe? | Current FCF multiple of China Feihe is 6.4x. |
| How many companies China Feihe has acquired to date? | As of May 2026, China Feihe has acquired 1 company. |
| What was the largest acquisition by China Feihe? | $28M acquisition of Vitamin World on 19th December 2017 was the largest M&A China Feihe has done to date. |
| What companies China Feihe acquired? | China Feihe acquired Vitamin World. |
| In how many companies China Feihe has invested to date? | As of May 2026, China Feihe has invested in 1 company. |
| What was the last China Feihe investment? | On 1st March 2021 China Feihe invested in Gushengtang Holdings, participating in a $38M Series E round, alongside Eight Roads Ventures, Long Hill Capital, and New Enterprise Associates. |
| In what companies China Feihe invested in? | China Feihe invested in Gushengtang Holdings. |
See public comps similar to China Feihe
Lists including China Feihe
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

